Zynex, through its subsidiary, Zynex Medical, Inc., designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. Co.'s devices are intended for pain management to reduce reliance on drugs and medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation, and transcutaneous electrical nerve stimulation. Co.'s primary product is the NexWave device. The ZYXI stock yearly return is shown above.
The yearly return on the ZYXI stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the ZYXI annual return calculation with any dividends reinvested as applicable (on ex-dates).
|